Viking Therapeutics (NASDAQ:VKTX) reported quarterly earnings results on February 11, 2026 that fell short of analyst expectations. The Healthcare company reported earnings per…
Viking Therapeutics (NASDAQ:VKTX) reported quarterly earnings results on February 11, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-1.38, missing the consensus estimate of $-0.90 by $0.48 per share. Revenue came in at , missing the estimate of $10.0M.
Viking Therapeutics's stock moved following the earnings release. The stock currently trades at $30.49 with a market capitalization of $4.2B.
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Current market data
NASDAQ · VKTX
$33.19
Up: +$0.25 · +0.76%
Live quote updated
Keep reading
analyst ·
earnings ·
earnings ·
sec_filing ·
